1 / 53

My Best Care Path for VATS Lobe: You Will Not Miss What You Do Not Need

My Best Care Path for VATS Lobe: You Will Not Miss What You Do Not Need. Robert J McKenna Jr. MD Head, Thoracic Surgery Cedars Sinai Medical Center. Presenter Disclosure Rob McKenna The following relationships exist related to this presentation :. Ethicon: Consultant, Speakers Bureau

elita
Download Presentation

My Best Care Path for VATS Lobe: You Will Not Miss What You Do Not Need

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. My Best Care Path for VATS Lobe: You Will Not Miss What You Do Not Need Robert J McKenna Jr. MD Head, Thoracic Surgery Cedars Sinai Medical Center

  2. Presenter DisclosureRob McKenna The following relationships exist related to this presentation: Ethicon: Consultant, Speakers Bureau Covidien: Speakers Bureau

  3. As medical student • Internal med rotation, given a symptom, given a patient’s symptom. Told to: • List 10 possible diagnoses • List 10 tests to rule out each diagnosis • ORDER THEM ALL???

  4. 2 weeks ago • ICU team over the weekend ordered: • 3 daily unchanged CXR’s • 3 daily unchanged, normal CBC’s • 3 daily unchanged, normal ionized Ca, Mag, Phosphate • 2 normal coag studies I WENT BALISTIC

  5. Fast-tracking after Lobectomy • Era of Cost Containment and Pay for Performance • Need to track our results and develop protocols to reduce costs and improve performance

  6. Fast-tracking: Protocol • No routine postoperative xrays • No routine postoperative labs • Remove chest tube when: • No air leak • Output < 300 ml hours • Discharge with Heimlich valve if persistent air leak and low output

  7. Fast-tracking: Results • 282 patients • 158 women (56%) • 124 men (44%) • Mean age 71.2 years • Range 46-95 years

  8. Fast-tracking: Age

  9. Fast-tracking: Age

  10. Fast-tracking: Results • RUL 107 LUL 74 • RML 17 LLL 30 • RLL 27 SEG 15 • BILOBE 1 SLEEVE 3 • RUL +LVRS 1 PNEUM 1 • Nissen/RUL 1

  11. Fast-tracking: Results • Lung Cancer 253 • Granuloma 8 • Carcinoid 6 • Pulmonary met 5 • Bronchiectasis 4 • Hamartoma 3 • Lymphoma 1 • Sequestration 1 • Solitary Fibrous Tumor 1

  12. Fast-tracking: Results • Mean LOS = 3.26 days • Median LOS = 3 days • Mortality = 1 (0.4%)

  13. Fast-tracking: Complications • None 251 (89.3%) • Air Leak 8 (2.8%) • AF 5 (1.8%) • Pneumonia 4 • Atelectasis 3 • Urinary Ret 2 • CVA/TIA 2 • Readmit 2 • RLN 2

  14. Fast-tracking: Complications • Empyema 1 • CDIFF 1 • Chylous drainage 1 • Confusion 1 • DVT 1 • Pyelonephritis 1 • Takeback 1

  15. Fast-tracking: Results • Blood tranfusion = 11 (3.9%) • Readmission = 2 • TIA • SQ emphysema

  16. Fast-tracking: Results • Reinsert chest tube: • none

  17. Fast-tracking: Conclusions • Routine use of ICU is not necessary • Routine use of labs and xrays is not necessary

  18. Fast-tracking: Conclusions Protocols may reduce length of stay and not compromise morbidity and mortality

  19. Fast-tracking: Look at costs Sealant costs $800 per dose

  20. Fast-tracking: Sealant Bertolaccinii JCTS 2010

  21. Chest Tube Management

  22. Fast-tracking: RCT: Suction / No Suction

  23. Fast-tracking: RCT: Suction / No Suction

  24. Fast-tracking: Suction / No Suction • Several RCT’s have shown shorter LOS with no suction • Level of evidence = 1

  25. Chest Tube RemovalOn suction or water seal? Martino

  26. Chest Tube RemovalOn suction or water seal? • Level 1 data • No difference in CT duration or LOS • Suction associated with increased PTX or CXR’s • If tube reinserted, double LOS Martino

  27. Fast-tracking: Chest Tube Management • Recommendations (level 1): • No suction on drainage system • No transition from suction to seal before removal

  28. Fast-tracking: Chest Tube Management • Use suction on drainage system: • Empyema • Increased postop drainage • Pleurodesis • Clinically Significant SQ air

  29. Chest Xrays

  30. Fast-tracking: Daily CXR in ICU • 525 routine daily CXR’s reviewed • 89 showed cardiopulmonary disease (12%) • 3 (0.006%) required intervention Silverstein

  31. Fast-tracking: Daily CXR in ICU • Recommendation: • Daily CXR not warranted • Order CXR only when clinically indicated

  32. Nebulizer Treatments 4

  33. Nebulizer Treatments • 25% of respiratory care procedures delivered were not indicated, whereas 12% of patients were not receiving respiratory care that was indicated 4

  34. Nebulizer Treatments • 2011 at Cedars Sinai, big push to order nebulizer only for proper indications • 60% reduction in nebulizer treatments 4

  35. Nebulizer Treatments • Not indicated for: • routine cases of pneumonia • Atelectasis • fever 4

  36. European Respiratory Society Nebulizer Guidelines • PCP Pneumonia • Nebulizedpentamidine is more effective than placebo but less effective than oral co-trimoxazole (Grade A) • Nosocomial pneumonia • HHN for treatment of hospital acquired pneumonia (Grade C) No RCT to prove benefit

  37. European Respiratory Society Nebulizer Guidelines • Surfactant for ARDS: • Improves gas exchange (Grade B) • RCT showed no improvement in outcome measurements (Grade A) • HHN for Pulmonary HTN • nebulizedprostacyclin (iloprost) (Grade A) • inhaled prostacyclin provide superior physiological outcomes (Grade B)

  38. European Respiratory Society Nebulizer Guidelines • Bronchoscopy: • HHN local anesthesia better than by bronchoscopy (Grade B) • HHN to reduce bronchospasm (Grade C)

  39. European Respiratory Society Nebulizer Guidelines • Lung Transplant: • steroids and nebulizedcyclosporin reduce obliterativebronchiolitis because of frequent episodes of rejection in the first 3 months post-transplantation. (Grade C)

  40. Chest Physiotherapy 4

  41. Fast-tracking: Resp Treatments • Indications for chest PT: • Difficulty expectorating secretions • Indications for nebulizer treatments: • Wheezing • Difficulty expectorating secretions

  42. Chest PT Guidelines: Meta-analysis • Hypercapneic Respiratory • Failure (pH 7.25-7.35, CO2 > 50) (Grade A) • Secretions (Grade A) • IPPB not recommended • PEP uncertain • Rosièrea, Swiss med 2009

  43. Chest PT / HHN Guidelines: Meta-analysis • Indications for chest PT / HHN: • Difficulty expectorating secretions • Wheezing • Rosièrea, Swiss med 2009

  44. Financial Impact of what we do 4

  45. Financial Pressures on Hospitals • Decreasing Reimbursement • Cost Containment by Hospitals • Attempts to Reduce support for Cardio Thoracic Surgery

  46. Revenue for Hospital Programs • Hospitalization • Downstream revenue • Lab tests • Xrays • Referrals to other programs

  47. Profit of Surg Specialties Resnick: Ann Surg, 2005

  48. Surgeon’s Productivity(Relative Value Units- RVU) • Thoracic and Transplant programs were the biggest surgical contributors to hospital profit margin Resnick: Ann Surg, 2005

  49. Medicare LobectomyProfit / hospital bed

  50. Medicare LobectomyProfit / hospital bed

More Related